Podcast: how femtech companies could navigate privacy and clinical safety requirements

Women’s health has never seen more prominence. Since 2016, when the term “femtech” was coined, the health sector serving half of the world’s population has been on an upward trajectory.

However, the “taboo” nature of women’s health and gender imbalances in investment are providing obstacles to the industry – femtech attracted only one per cent of health tech investments in 2022.

On top of that, the sector also faces significant challenges around regulatory compliance.

In this week’s podcast episode, we sat down with Amy Ford, data privacy specialist and managing director at Kaleidoscope, to find out how femtech companies could navigate privacy and clinical safety requirements.